German chemical giant Bayer AG on Wednesday said it had agreed to pay more than US$10 billion to end a wave of lawsuits from Americans who say their cancers were caused by its Roundup weedkiller.
The deal relieves a major headache for Bayer, which has been going on since it bought US firm and Roundup maker Monsanto Co for US$63 billion in 2018.
“The Roundup settlement is the right action at the right time for Bayer to bring a long period of uncertainty to an end,” CEO Werner Baumann said in a statement.
At the same time, Bayer announced it had also agreed to separate multimillion-dollar payouts to resolve longstanding legal issues involving other Bayer products, as the group tries to turn the page on its courtroom dramas.
Bayer’s share price climbed nearly 6 percent to 74.06 euros in after-hours trading following the surprise announcement.
The Roundup deal would bring closure to about 75 percent of current litigation that involves about 125,000 filed and unfiled claims, the statement said.
It would also settle about 95 percent of the cases currently set for trial and establish “key values and parameters” to resolve the remainder of the claims, Bayer added.
Roundup is a flagship Monsanto product containing glyphosate, a widely used weedkiller that tens of thousands of plaintiffs say caused their illness — with many suffering from non-Hodgkin’s lymphoma.
Bayer last year faced a group of financially painful setbacks in first-instance US court rulings, although the amounts awarded were later reduced.
Jennifer Moore, a lawyer representing several Roundup plaintiffs, welcomed the deal.
“This settlement is significant for our clients because this has been a long, hard-fought battle and it brings justice for our clients,” she said.
Bayer maintains that scientific studies and regulatory approvals show Roundup’s main ingredient glyphosate is safe, but said in April when it released first-quarter earnings data that it “continues to engage constructively in the mediation process.”
The settlement consists of a payment of US$8.8 billion to US$9.6 billion to resolve the current Roundup litigation, Bayer said, and US$1.25 billion to address potential future litigation.
Bayer said that the agreement would not cover three cases currently going through the appeals process.
They include the landmark first Roundup case brought by school groundskeeper Dewayne Johnson who was eventually awarded US$78.5 million.
In the same statement, Bayer said it would pay US$820 million to settle decades-old complaints over Monsanto-made toxic chemicals known as PCBs that caused water contamination.
It also agreed to settle US lawsuits involving dicamba herbicide which has been blamed for wrecking crops in the US, by drifting on to plants unable to resist it.
The group said it would pay up to US$400 million to resolve pending claims in Missouri for the 2012 to 2015 crop years.
Bayer said it expects codefendant BASF AG — which also manufacturers a type of dicamba — to contribute toward the settlement.
It comes after a US jury in February awarded US$265 million to Missouri peach farmer Bill Bader who accused the companies of encouraging farmers to use the weedkiller irresponsibly.
Bayer said it would make the first cash payments related to the mass settlements starting this year.
Part of the funds would come from the sale of its profitable animal health unit.
DIVIDED VIEWS: Although the Fed agreed on holding rates steady, some officials see no rate cuts for this year, while 10 policymakers foresee two or more cuts There are a lot of unknowns about the outlook for the economy and interest rates, but US Federal Reserve Chair Jerome Powell signaled at least one thing seems certain: Higher prices are coming. Fed policymakers voted unanimously to hold interest rates steady at a range of 4.25 percent to 4.50 percent for a fourth straight meeting on Wednesday, as they await clarity on whether tariffs would leave a one-time or more lasting mark on inflation. Powell said it is still unclear how much of the bill would fall on the shoulders of consumers, but he expects to learn more about tariffs
NOT JUSTIFIED: The bank’s governor said there would only be a rate cut if inflation falls below 1.5% and economic conditions deteriorate, which have not been detected The central bank yesterday kept its key interest rates unchanged for a fifth consecutive quarter, aligning with market expectations, while slightly lowering its inflation outlook amid signs of cooling price pressures. The move came after the US Federal Reserve held rates steady overnight, despite pressure from US President Donald Trump to cut borrowing costs. Central bank board members unanimously voted to maintain the discount rate at 2 percent, the secured loan rate at 2.375 percent and the overnight lending rate at 4.25 percent. “We consider the policy decision appropriate, although it suggests tightening leaning after factoring in slackening inflation and stable GDP growth,”
Greek tourism student Katerina quit within a month of starting work at a five-star hotel in Halkidiki, one of the country’s top destinations, because she said conditions were so dire. Beyond the bad pay, the 22-year-old said that her working and living conditions were “miserable and unacceptable.” Millions holiday in Greece every year, but its vital tourism industry is finding it harder and harder to recruit Greeks to look after them. “I was asked to work in any department of the hotel where there was a need, from service to cleaning,” said Katerina, a tourism and marketing student, who would
i Gasoline and diesel prices at fuel stations are this week to rise NT$0.1 per liter, as tensions in the Middle East pushed crude oil prices higher last week, CPC Corp, Taiwan (台灣中油) and Formosa Petrochemical Corp (台塑石化) said yesterday. International crude oil prices last week rose for the third consecutive week due to an escalating conflict between Israel and Iran, as the market is concerned that the situation in the Middle East might affect crude oil supply, CPC and Formosa said in separate statements. Front-month Brent crude oil futures — the international oil benchmark — rose 3.75 percent to settle at US$77.01
RSS